Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alain Stricker-Krongrad is active.

Publication


Featured researches published by Alain Stricker-Krongrad.


Bioorganic & Medicinal Chemistry Letters | 2010

3-Indolyl sultams as selective CRTh2 antagonists.

L. Nathan Tumey; Michael J. Robarge; Elizabeth Gleason; Jianping Song; Steven M. Murphy; George Mbella Ekema; Chris Doucette; Doug Hanniford; Marc Palmer; Gary Pawlowski; Joel Danzig; Margaret Loftus; Karen Hunady; Bruce Sherf; Robert W. Mays; Alain Stricker-Krongrad; Kurt R. Brunden; Youssef L. Bennani; John J. Harrington

CRTh2 (DP(2)) is a prostaglandin D(2) receptor implicated in the recruitment of eosinophils and basophils within the asthmatic lung. Here we report the discovery of a novel series of 3-indolyl sultam antagonists with low nM affinity for CRTh2. These compounds proved to be selective over the other primary prostaglandin D(2) receptor (DP1) as well as the thromboxane A(2) receptor (TP).


Brain Research | 2004

Feeding response to a potent prolactin-releasing peptide agonist in lean and obese Zucker rats.

Bernard Beck; Sébastien Richy; Alain Stricker-Krongrad

Prolactin (PRL)-releasing peptide (PrRP) is a new peptide present in the hypothalamus and in the circulation that may be involved in the regulation of feeding behavior. In the present experiment, we measured it in a well-known model of obesity, the Zucker rat. We also measured the reactivity of this animal in terms of food intake after the intraperitoneal (I.P.) or central injection of PrRP-13, a potent PrRP agonist. Plasma PrRP levels were 35% lower in obese fa/fa than in the lean rats (p<0.005). I.P. injections of PrRP-13 (10 mg/kg) stimulated food intake in lean and had no effect in obese rats (p<0.001). Intracerebral injections of PrRP-13 had no effects in both genotypes. Altogether, these results do not support a role for PrRP in the hyperphagia and obesity syndrome of the Zucker rat.


Bioorganic & Medicinal Chemistry Letters | 2010

Investigation of 4-piperidinols as novel H3 antagonists.

James T. Anderson; Michael G. Campbell; Jianmin Wang; Kurt R. Brunden; John J. Harrington; Alain Stricker-Krongrad; Jianping Song; Chris Doucette; Steven M. Murphy; Youssef L. Bennani

Compounds containing a substituted 4-piperidinol core have been found to be potent antagonists of the human H(3) receptor. The compounds exhibited up to a 60-fold preference for inhibiting the human H(3) receptor over the mouse and showed a low binding affinity for the hERG channel.


Life Sciences | 2004

Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats

Bernard Beck; Sébastien Richy; Alain Stricker-Krongrad


Journal of Medicinal Chemistry | 2005

Identification of novel and improved antimitotic agents derived from noscapine.

James T. Anderson; Anthony E. Ting; Sherry Boozer; Kurt R. Brunden; Chris Crumrine; Joel Danzig; Tom Dent; Laurel Faga; John J. Harrington; William F. Hodnick; Steven M. Murphy; Gary Pawlowski; Robert Perry; Amy Raber; Stephen Rundlett; Alain Stricker-Krongrad; Jianmin Wang; Youssef L. Bennani


Journal of Pharmacological and Toxicological Methods | 2006

Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel.

Steven M. Murphy; Marc Palmer; Michelle Fontilla Poole; Linas Padegimas; Karen Hunady; Joel Danzig; Sikander Gill; Rajwant Gill; Anthony E. Ting; Bruce Sherf; Kurt R. Brunden; Alain Stricker-Krongrad


Bioorganic & Medicinal Chemistry Letters | 2005

Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists

Michael J. Robarge; David C. Bom; L. Nathan Tumey; Norbert Varga; Elizabeth Gleason; Daniel P. Silver; Jianping Song; Steven M. Murphy; George Mbella Ekema; Chris Doucette; Doug Hanniford; Marc Palmer; Gary Pawlowski; Joel Danzig; Margaret Loftus; Karen Hunady; Bruce Sherf; Robert W. Mays; Alain Stricker-Krongrad; Kurt R. Brunden; John J. Harrington; Youssef L. Bennani


Assay and Drug Development Technologies | 2005

Development of Homogeneous High-Affinity Agonist Binding Assays for 5-HT2 Receptor Subtypes

Jianping Song; Doug Hanniford; Chris Doucette; E. Graham; M.F. Poole; A. Ting; Bruce Sherf; John J. Harrington; Kurt R. Brunden; Alain Stricker-Krongrad


Bioorganic & Medicinal Chemistry Letters | 2006

The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists

Bayard Huck; Luis Llamas; Michael J. Robarge; Thomas C. Dent; Jianping Song; William F. Hodnick; Chris Crumrine; Alain Stricker-Krongrad; John J. Harrington; Kurt R. Brunden; Youssef L. Bennani


Bioorganic & Medicinal Chemistry Letters | 2006

The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist

Bayard Huck; Luis Llamas; Michael J. Robarge; Thomas C. Dent; Jianping Song; William F. Hodnick; Chris Crumrine; Alain Stricker-Krongrad; John J. Harrington; Kurt R. Brunden; Youssef L. Bennani

Collaboration


Dive into the Alain Stricker-Krongrad's collaboration.

Top Co-Authors

Avatar

Kurt R. Brunden

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Nancy Wang

University of Melbourne

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge